Atlas Trials

An Observational Study to Learn More About Vericiguat Treatment Patterns and Its Safety in People With Chronic Heart Failure With Reduced Ejection Fraction in Routine Medical Care in the United States

Clinical trial NCT06363110 · COMPLETED

Trial details

NCT number
NCT06363110
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Heart Failure With Reduced Ejection Fraction
Start date
2024-04-10
Primary completion
2024-06-24
Enrollment
1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.